MAPT and Alzheimer disease: Our findings suggest that tau polymorphisms play a significant role in disease resilience, with tau oligomers from NDAN individuals exhibiting structural differences associated with lower neuronal toxicity, contributing to cognitive resilience despite the presence of AD‐like pathology.